Back

Betrixaban compared to enoxaparin among obese acute medically ill subjects: an APEX trial subgroup analysis

25 August 2018 (12:03 - 12:12)
Organised by:
Congress Presentation Part of: Obesity and cardiovascular disease Obesity ESC Premium Access ESC Congress 2018

About the speaker

Photo
Miss Megan Yee

Boston (United States of America)

8 More presentations in this session

Presentation thumbnail
Obesity, fitness and the risk of incident atrial fibrillation in healthy adults
Doctor A. Younis (Rochester, US)
Abstract Slides Video
Presentation thumbnail
Metabolically healthy obesity is associated with a distinct epicardial fat phenotype and low myocardial oxidative stress
Doctor A. Antonopoulos (Athens, GR)
Abstract
Presentation thumbnail
Epicardial obesity as one of the significant predictors of subclinical multifocal atherosclerosis
Doctor A. Ott (Barnaul, RU)
Abstract Slides Video
Presentation thumbnail
Gender disparities of distribution of epicardial adipose tissue and its impact on coronary artery disease
Doctor G. Maimaituxun (Fukushima, JP)
Abstract Slides Video
Presentation thumbnail
Very low calorie diets lead to temporary and reversible left ventricular impairment
Doctor J. Rayner (Oxford, GB)
Abstract

Access the full session

Session thumbnail
Obesity and cardiovascular disease

The Event

Event poster

ESC Congress 2018

25 August 2018 12:03 CET
You may be interested in
thumbnail
Congress Session
Obesity as a cardiovascular disease: integrated management
thumbnail
Webinar
Obesity management: implications for cardiovascular risk reduction
thumbnail
Congress Session
ESC Clinical Consensus Statement on Obesity and Cardiovascular Disease

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources